Resources Contact Us Home
Internalizing anti-CD74 antibodies and methods of use

Image Number 15 for United States Patent #7931903.

The present invention provides humanized, chimeric and human anti-CD74 antibodies, CD74 antibody fusion proteins, immunoconjugates, vaccines and bispecific that bind to CD74, the major histocompatibility complex (MHC) class-II invariant chain, Ii, which is useful for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies, other malignancies in which the cells are reactive with CD74, and autoimmune diseases, and methods of treatment and diagnosis.

  Recently Added Patents
Memory circuit and method of forming the same using reduced mask steps
Combination photovoltaic and wind power generation installation
Isolated nucleic acid molecule encoding an antibody that reduces GDF-8 activity
Unsupervised document clustering using latent semantic density analysis
Fingerprinting apparatus, system, and method
Digital image processing device and processing method thereof
Method and system for reciprocal mixing cancellation of wideband modulated blockers
  Randomly Featured Patents
Assembling structure for a door lock
Unitized barrier and flow control device for electrochemical reactors
Handheld scanner with high image quality
Methods and apparatus for providing an extremely fast response in switching power converters
Method of reducing gastric secretion
Radiator manufacturing method and aligning-and-moving mechanism thereof
Method and apparatus in connection with an inhaler
Sheer stretch hose having high compressive force uniformity, and yarn
Liquid crystal display device
Automotive wheel